v3.25.2
Derivative Instruments
 6 Months Ended
Jun. 28, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments Derivative Instruments
In the normal course of business, the Company is exposed to global market risks, including the effects of changes in foreign currency exchange rates and interest rates. The Company commonly uses derivative instruments to manage its exposure to such risks and may elect to designate certain derivatives as hedging instruments under ASC Topic 815, Derivatives and Hedging (“ASC 815”). The Company formally documents all relationships between designated hedging instruments and hedged items as well as its risk management objectives and strategies for undertaking hedge transactions. The Company does not hold or issue derivatives for trading or speculative purposes.

In accordance with ASC 815, the Company recognizes derivative instruments as either assets or liabilities on the Consolidated Balance Sheets and measures them at fair value. The following table presents the fair value of its derivative instruments (in millions):
Asset (Liability)
Fair Values as of
Balance Sheets ClassificationJune 28,
2025		December 31,
2024
Derivative instruments designated as hedges:
    Foreign exchange contractsPrepaid expenses and other current assets$— $30 
    Foreign exchange contractsAccrued liabilities(51)— 
Total derivative instruments designated as hedges$(51)$30 
Derivative instruments not designated as hedges:
    Foreign exchange contractsPrepaid expenses and other current assets$— $1 
    Foreign exchange contractsAccrued liabilities(6)— 
Total derivative instruments not designated as hedges$(6)$1 
Total net derivative (liability) asset$(57)$31 
The following table presents the net gains (losses) from changes in fair values of derivatives that are not designated as hedges (in millions):
Gains (Losses) Recognized in Income
 Three Months EndedSix Months Ended
Statements of Operations ClassificationJune 28,
2025		June 29,
2024		June 28,
2025		June 29,
2024
Derivative instruments not designated as hedges:
Foreign exchange contractsForeign exchange (loss) gain$(15)$1 $(23)$2 
Forward interest rate swapsInterest expense, net— 11 — 31 
Total net (loss) gain recognized in income$(15)$12 $(23)$33 

Activities related to derivative instruments are reflected within Net cash provided by operating activities on the Consolidated Statements of Cash Flows.

Interest Rate Risk Management
The Company is exposed to market risk associated with interest rate payments on its borrowings under a term loan (“Term Loan A”), Revolving Credit Facility, and Receivables Financing Facilities, which bear interest at variable rates plus applicable margins. The Company manages its exposure to changes in interest rates by issuing both fixed and variable rate borrowings as well as periodically utilizing interest rate swaps to economically hedge interest rate exposure based on current and projected market conditions. The Company had no active interest rate swap agreements during the six months ended June 28, 2025.
Credit and Market Risk Management
Financial instruments, including derivatives, expose the Company to counterparty credit risk of nonperformance and to market risk related to currency exchange rate and interest rate fluctuations. The Company manages its exposure to counterparty credit risk by establishing minimum credit standards, diversifying its counterparties, and monitoring its concentrations of credit. The Company’s counterparties are commercial banks with expertise in derivative financial instruments. The Company evaluates the impact of market risk on the fair value and cash flows of its derivative and other financial instruments by considering reasonably possible changes in interest rates and currency exchange rates. The Company continually monitors the creditworthiness of the customers to which it grants credit terms in the normal course of business. The terms and conditions of the Company’s credit policies are designed to mitigate concentrations of credit risk.

The Company’s master netting and other similar arrangements with the respective counterparties allow for net settlement under certain conditions, which are designed to reduce credit risk by permitting net settlement with the same counterparty. We present the assets and liabilities of our derivative financial instruments, for which we have net settlement agreements in place, on a net basis on the Consolidated Balance Sheets. If the derivative financial instruments had been presented gross on the Consolidated Balance Sheets, the asset and liability positions would not have been significantly different as of June 28, 2025 or December 31, 2024.

Foreign Currency Exchange Risk Management
The Company conducts business on a multinational basis in a variety of foreign currencies. Exposure to market risk for changes in foreign currency exchange rates arises primarily from Euro-denominated external revenues, cross-border financing activities between subsidiaries, and foreign currency denominated monetary assets and liabilities. The Company manages its objective of preserving the economic value of non-functional currency denominated cash flows by initially hedging transaction exposures with natural offsets and, once these opportunities have been exhausted, through foreign exchange forward and option contracts, as deemed appropriate.

The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) (“AOCI”) on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $13 million of losses and $5 million of gains for the three months ended June 28, 2025 and June 29, 2024, respectively. Realized amounts reclassified to Net sales were $4 million of losses and $6 million of gains for the six months ended June 28, 2025 and June 29, 2024, respectively. As of June 28, 2025 and December 31, 2024, the notional amounts of the Company’s foreign exchange cash flow hedges were €611 million and €592 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective.

The Company uses forward contracts, which are not designated as hedging instruments, to manage its exposures related to net assets denominated in foreign currencies. These forward contracts typically mature within one month after execution. Monetary gains and losses on these forward contracts are recorded in income and are generally offset by the transaction gains and losses related to their net asset positions. The notional values and the net fair values of these outstanding contracts were as follows (in millions):
 June 28,
2025		December 31,
2024
Notional balance of outstanding contracts:
British Pound/U.S. Dollar£2 £5 
Euro/U.S. Dollar€102 €146 
Euro/Czech Koruna€14 €16 
Japanese Yen/U.S. Dollar¥662 ¥360 
Singapore Dollar/U.S. DollarS$13 S$23 
Mexican Peso/U.S. DollarMex$234 Mex$142 
Polish Zloty/U.S. Dollarzł89 zł53 
Net fair value of (liabilities) assets of outstanding contracts$(6)$1